Código QR (código de barras bidimensional)

Efficacy of venetoclax in the treatment of relapsed/refractory light-chain amyloidosis

Abstract Few studies have reported that venetoclax, a selective BCL2 inhibitor, has shown promising efficacy in relapsed/refractory AL amyloidosis (RRAL), especially among patients harboring t(11;14). We retrospectively reviewed 29 RRAL patients treated with venetoclax between July 2022 and January...

Fuld beskrivelse

Na minha lista:
Principais autores: Xin-yi Xiong, Ai Guan, Yi Xu, Cheng-yang Xu, Kai-ni Shen, Jian Li
Format: Artigo
Sprog:Inglês
Udgivet: Springer 2025-11-01
Serier:Annals of Hematology
Fag:
Light chain amyloidosis
Venetoclax
T(11;14)
Relapsed/refractory
Hematologic response
Online adgang:https://doi.org/10.1007/s00277-025-06716-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker